BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29074562)

  • 1. Expanding the clinical spectrum of recessive truncating mutations of
    Bruel AL; Bigoni S; Kennedy J; Whiteford M; Buxton C; Parmeggiani G; Wherlock M; Woodward G; Greenslade M; Williams M; St-Onge J; Ferlini A; Garani G; Ballardini E; van Bon BW; Acuna-Hidalgo R; Bohring A; Deleuze JF; Boland A; Meyer V; Olaso R; Ginglinger E; Study D; Rivière JB; Brunner HG; Hoischen A; Newbury-Ecob R; Faivre L; Thauvin-Robinet C; Thevenon J
    J Med Genet; 2017 Dec; 54(12):830-835. PubMed ID: 29074562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel PTC mutation in the BTB domain of KLHL7 gene in two patients with Bohring-Opitz syndrome-like features.
    Cheraghi S; Moghbelinejad S; Najmabadi H; Kahrizi K; Najafipour R
    Eur J Med Genet; 2020 Apr; 63(4):103849. PubMed ID: 31953236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bi-allelic c.181_183delTGT in BTB domain of KLHL7 is associated with overlapping phenotypes of Crisponi/CISS1-like and Bohring-Opitz like syndrome.
    Kanthi A; Hebbar M; Bielas SL; Girisha KM; Shukla A
    Eur J Med Genet; 2019 Jun; 62(6):103528. PubMed ID: 30142437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa.
    Angius A; Uva P; Buers I; Oppo M; Puddu A; Onano S; Persico I; Loi A; Marcia L; Höhne W; Cuccuru G; Fotia G; Deiana M; Marongiu M; Atalay HT; Inan S; El Assy O; Smit LM; Okur I; Boduroglu K; Utine GE; Kılıç E; Zampino G; Crisponi G; Crisponi L; Rutsch F
    Am J Hum Genet; 2016 Jul; 99(1):236-45. PubMed ID: 27392078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two siblings with a novel nonsense variant provide further delineation of the spectrum of recessive KLHL7 diseases.
    Jeffries L; Olivieri JE; Ji W; Spencer-Manzon M; Bale A; Konstantino M; Lakhani SA
    Eur J Med Genet; 2019 Sep; 62(9):103551. PubMed ID: 30300710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in the 3-box motif of the BACK domain of KLHL7 associated with nonsyndromic autosomal dominant retinitis pigmentosa.
    Oh JK; Lima de Carvalho JR; Sun YJ; Ragi S; Yang J; Levi SR; Ryu J; Bassuk AG; Mahajan VB; Tsang SH
    Orphanet J Rare Dis; 2019 Dec; 14(1):295. PubMed ID: 31856884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother.
    Bedoukian E; Copenheaver D; Bale S; Deardorff M
    Am J Med Genet A; 2018 May; 176(5):1249-1252. PubMed ID: 29681100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.
    Carlston CM; O'Donnell-Luria AH; Underhill HR; Cummings BB; Weisburd B; Minikel EV; Birnbaum DP; ; Tvrdik T; MacArthur DG; Mao R
    Hum Mutat; 2017 May; 38(5):517-523. PubMed ID: 28229513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New macular findings in individuals with biallelic KLHL7 gene mutation.
    Heng LZ; Kennedy J; Smithson S; Newbury-Ecob R; Churchill A
    BMJ Open Ophthalmol; 2019; 4(1):e000234. PubMed ID: 30997404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crisponi/cold-induced sweating syndrome: Differential diagnosis, pathogenesis and treatment concepts.
    Buers I; Persico I; Schöning L; Nitschke Y; Di Rocco M; Loi A; Sahi PK; Utine GE; Bayraktar-Tanyeri B; Zampino G; Crisponi G; Rutsch F; Crisponi L
    Clin Genet; 2020 Jan; 97(1):209-221. PubMed ID: 31497877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular genetic findings of Crisponi/cold-induced sweating syndrome (CS/CISS) spectrum in patients from Turkey.
    Yilmaz Gulec E; Turgut GT; Gezdirici A; Karaman V; Ozturk FN; Avci S; Kalayci T; Senturk L; Ayaz A; Kayserili H; Uyguner ZO; Altunoğlu U
    Clin Genet; 2022 Sep; 102(3):201-217. PubMed ID: 35699517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.
    Urreizti R; Roca-Ayats N; Trepat J; Garcia-Garcia F; Aleman A; Orteschi D; Marangi G; Neri G; Opitz JM; Dopazo J; Cormand B; Vilageliu L; Balcells S; Grinberg D
    Am J Med Genet A; 2016 Jan; 170A(1):24-31. PubMed ID: 26768331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel truncating mutations in ASXL1 identified in two boys with Bohring-Opitz syndrome.
    Zhao J; Hou Y; Fang F; Ding C; Yang X; Li J; Cui D; Cao Z; Zhang H
    Eur J Med Genet; 2021 Mar; 64(3):104155. PubMed ID: 33529703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal persistent pulmonary hypertension of the newborn in Bohring-Opitz syndrome.
    Kibe M; Ibara S; Inagaki H; Kato T; Kurahashi H; Ikeda T
    Am J Med Genet A; 2018 May; 176(5):1245-1248. PubMed ID: 29681105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel de-novo frameshift mutation of the ASXL1 gene in a classic case of Bohring-Opitz syndrome.
    Arunachal G; Danda S; Omprakash S; Kumar S
    Clin Dysmorphol; 2016 Jul; 25(3):101-5. PubMed ID: 27043953
    [No Abstract]   [Full Text] [Related]  

  • 16. Bohring-opitz syndrome - A case of a rare genetic disorder.
    Visayaragawan N; Selvarajah N; Apparau H; Kamaru Ambu V
    Med J Malaysia; 2017 Aug; 72(4):248-249. PubMed ID: 28889139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extending the phenotypic spectrum of Bohring-Opitz syndrome: Mild case confirmed by functional studies.
    Leon E; Diaz J; Castilla-Vallmanya L; Grinberg D; Balcells S; Urreizti R
    Am J Med Genet A; 2020 Jan; 182(1):201-204. PubMed ID: 31692235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.
    Russell B; Johnston JJ; Biesecker LG; Kramer N; Pickart A; Rhead W; Tan WH; Brownstein CA; Kate Clarkson L; Dobson A; Rosenberg AZ; Vergano SA; Helm BM; Harrison RE; Graham JM
    Am J Med Genet A; 2015 Sep; 167A(9):2122-31. PubMed ID: 25921057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.
    Dangiolo SB; Wilson A; Jobanputra V; Anyane-Yeboa K
    Am J Med Genet A; 2015 Dec; 167A(12):3161-6. PubMed ID: 26364555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the clinical and mutational spectrum of Kaufman oculocerebrofacial syndrome with biallelic UBE3B mutations.
    Basel-Vanagaite L; Yilmaz R; Tang S; Reuter MS; Rahner N; Grange DK; Mortenson M; Koty P; Feenstra H; Farwell Gonzalez KD; Sticht H; Boddaert N; Désir J; Anyane-Yeboa K; Zweier C; Reis A; Kubisch C; Jewett T; Zeng W; Borck G
    Hum Genet; 2014 Jul; 133(7):939-49. PubMed ID: 24615390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.